Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation

Manuela Funke-Chambour, Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Athol U. Wells, Jacques Cadranel

Source: ERJ Open Res, 8 (4) 00469-2022; 10.1183/23120541.00469-2022
Journal Issue: October

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Manuela Funke-Chambour, Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Athol U. Wells, Jacques Cadranel. Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation. ERJ Open Res, 8 (4) 00469-2022; 10.1183/23120541.00469-2022

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.